It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events.
Ideaya Biosciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $43.18 and fluctuated between $43.71 as its day high and $42.68 as its day low. The current market capitalization of Ideaya Biosciences Inc is $3.18B. A total of 1.03 million shares were traded on the day, compared to an average of 1.02M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, IDYA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 12 BUYs and 17 SELLs from insiders. Insiders purchased 48,571 shares during that period but sold 43,470.
In the most recent transaction, Hata Yujiro S sold 628 shares of IDYA for 45.00 per share on Feb 01. After the transaction, the President and CEO now owns 677,887 company shares. In a previous transaction on Jan 22, Ruiz Briseno Andres sold 2,000 shares at 42.03 per share. IDYA shares that the insider owns now total 26,531.
Among the insiders who sold shares, Hata Yujiro S disposed of 62,739 shares on Jan 16 at a per-share price of $40.17. This resulted in the President and CEO holding 677,887 shares of IDYA after the transaction. In another insider transaction, Hata Yujiro S sold 12,261 shares at $40.04 per share on Jan 12. Company shares held by the President and CEO now total 677,887.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IDYA has a high of $45.00 and a low of $13.29.
As of this writing, IDYA has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.66. The company reported an EPS of -$0.5 in the last quarter, which was 10.70% higher than expectations of -$0.56.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IDYA’s latest balance sheet shows that the firm has $246.77M in Cash & Short Term Investments as of fiscal 2021. There were $5.18M in debt and $45.16M in liabilities at the time. Its Book Value Per Share was $8.67, while its Total Shareholder’s Equity was $301.51M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IDYA is Buy with a score of 4.91.